Solvay has opened new facility in Bad Wimpfen, Germany

Solvay opens ETFBO facility in Bad Wimpfen, Germany

11:06 AM, 11th November 2014
Solvay has opened a new facility in Bad Wimpfen, Germany

BAD WIMPFEN, GERMANY: Solvay has opened a new facility in Bad Wimpfen, Germany to produce the synthetic building block 4-ethoxy-1,1,1-trifluoro-3-butene-2-one (ETFBO), expanding its range of fluorinated organic intermediates. The new € 5 million facility has a capacity of 1,000 tonne per year. Construction of the facility, integrated into an existing building, began in May this year and preliminary sample amounts were produced in October.

“Solvay in Bad Wimpfen is our most important site for the production of these fluorinated specialty chemicals and the only ETFBO supplier worldwide. Our local research know-how, qualified staff and many years of production experience are unique worldwide, giving us a competitive advantage. An additional benefit is that we are close to our key customers, manufacturers of agrochemicals,” said Horst Kroger, Head of Strategic Marketing, Global Business Unit Special Chemicals, Solvay.

Related News - Solvay Acetow, Accsys to develop high performance wood

© Worldofchemicals News



Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News

Sumitomo, Monsanto strengthen weed management partnership in US

TOKYO, JAPAN/ST LOUIS, US: Sumitomo Chemical has reached an agreement with Monsanto Company to strengthen its strategic partnership for the companies& ...

Read more
Styrolution to close polystyrene production site in Trelleborg, Sweden

FRIBOURG, SWITZERLAND: Styrolution intends to close its 80 kilotonne polystyrene production site located in Trelleborg, Sweden, in order to further st ...

Read more
ScinoPharm, Nanjing King-friend Biochemical JV for new drug in China

TAINAN, TAIWAN: ScinoPharm Taiwan, Ltd and Nanjing King-friend Biochemical Pharmaceutical Co Ltd (NKF) announced the joint research and development of ...

Read more
New catalyst could produce pure hydrogen through electrolysis

STANFORD, US: Chemical engineers at Stanford University have designed a catalyst that could help produce vast quantities of pure hydrogen through elec ...

Read more
New laser technology to diagnose cardiovascular disease

WEST LAFAYETTE, US: Researchers are close to commercializing a new type of medical imaging technology that could diagnose cardiovascular disease by me ...

Read more
Advent, Avista to acquire UCB’s US specialty generics subsidiary

BRUSSELS, BELGIUM: UCB, Advent International and Avista Capital Partners, two leading private equity firms with a strong healthcare focus, have entere ...

Read more uses cookies to ensure that we give you the best experience on our website. By using this site, you agree to our Privacy Policy and our Terms of Use. X